NicErase-SL: Began a multicenter Phase III trial

DynaGen Inc. (DYGN), Cambridge, Mass. Product: NicErase-SL Indication: Smoking cessation Status: Began a multicenter Phase III trial with NicErase-SL, a non-nicotine sublingual tablet, as an aid in sm...